Skip to main content
. Author manuscript; available in PMC: 2015 Sep 8.
Published in final edited form as: Am J Surg Pathol. 2012 Mar;36(3):443–453. doi: 10.1097/PAS.0b013e31823b13fe

TABLE 7.

Details for Figures

Figure Consensus Diagnoses/Interpretations
Final Diagnosis (Genotyping Result)
Round 1* Round 2* Round 3 (With p57)* p57* w
2A-D CHM (3/3) CHM (3/3) CHM (3/3) Negative (3/3) CHM (androgenetic diploidy)
2E-H CHM (3/3) CHM (3/3) CHM (3/3) Negative (3/3) CHM (androgenetic diploidy)
2I-L PHM (3/3) PHM (3/3) PHM (3/3) Positive (3/3) PHM (diandric triploidy)
2M-P PHM (2/3) PHM (2/3) CHM (3/3) Negative (3/3) CHM (androgenetic diploidy)
3A-D None NM (2/3) CHM (3/3) Negative (3/3) CHM (androgenetic diploidy)
3E-H NM (2/3) NM (3/3) NM (2/3) Positive (3/3) PHM (diandric triploidy)
3I-L PHM (2/3) NM (3/3) PHM (2/3) Positive (3/3) NM (abnormal villous morphology) (biparental diploidy, trisomy 16 and 21)
3M-P PHM (2/3) PHM (2/3) NM (2/3) Positive (3/3)zy NM (mosaic/chimeric) (androgenetic/biparental diploidy)
*

Result (no. pathologists rendering the diagnosis/interpretation).

The p57 result for all observers for each case was concordant with the officially reported p57 interpretation.

Two of 3 pathologists recognized a discordant pattern.

§

Mosaic/chimeric conception with p57 expression in villous cytotrophoblast but not in villous stromal cells (see Ronnett et al51 for additional details of p57 expression patterns in mosaic/chimeric conceptions).

CHM, complete hydatidiform mole (either classic or early type); NM, non-molar specimen; PHM, partial hydatidiform mole.